Jukka Hakkola

6.6k total citations · 1 hit paper
93 papers, 5.2k citations indexed

About

Jukka Hakkola is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Jukka Hakkola has authored 93 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pharmacology, 37 papers in Molecular Biology and 27 papers in Oncology. Recurrent topics in Jukka Hakkola's work include Pharmacogenetics and Drug Metabolism (48 papers), Drug Transport and Resistance Mechanisms (23 papers) and Hormonal Regulation and Hypertension (18 papers). Jukka Hakkola is often cited by papers focused on Pharmacogenetics and Drug Metabolism (48 papers), Drug Transport and Resistance Mechanisms (23 papers) and Hormonal Regulation and Hypertension (18 papers). Jukka Hakkola collaborates with scholars based in Finland, Sweden and United States. Jukka Hakkola's co-authors include Olavi Pelkonen, Hannu Raunio, Janne Hukkanen, Miia Turpeinen, Marcin Buler, Markku Pasanen, Paavo Honkakoski, Sisko Anttila, Jaana Rysä and Alan R. Boobis and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jukka Hakkola

93 papers receiving 5.0k citations

Hit Papers

Inhibition and induction of CYP enzymes in humans: an update 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jukka Hakkola Finland 44 2.1k 1.6k 1.1k 699 597 93 5.2k
Michael W.H. Coughtrie United Kingdom 42 2.1k 1.0× 2.6k 1.6× 871 0.8× 783 1.1× 634 1.1× 139 6.2k
Markku Pasanen Finland 37 1.9k 0.9× 1.3k 0.8× 932 0.8× 739 1.1× 416 0.7× 138 4.8k
Jorge Goldstein United States 34 2.2k 1.1× 1.0k 0.6× 1.1k 1.0× 468 0.7× 528 0.9× 88 4.6k
Norie Murayama Japan 39 3.1k 1.5× 1.2k 0.8× 1.6k 1.5× 448 0.6× 386 0.6× 235 5.0k
Kouichi Yoshinari Japan 32 1.7k 0.8× 1.3k 0.8× 1.0k 0.9× 462 0.7× 245 0.4× 153 3.6k
Ronald N. Hines United States 45 2.5k 1.2× 1.6k 1.0× 1.2k 1.1× 1.4k 2.0× 866 1.5× 128 6.4k
Jean‐Marc Pascussi France 40 2.8k 1.3× 1.6k 1.0× 1.8k 1.6× 531 0.8× 469 0.8× 92 5.9k
Curtis J. Omiecinski United States 47 2.8k 1.4× 2.5k 1.5× 1.2k 1.1× 488 0.7× 836 1.4× 117 7.5k
Burhan I. Ghanayem United States 37 2.2k 1.1× 1.1k 0.7× 1.2k 1.1× 390 0.6× 914 1.5× 94 5.6k
Petr Pávek Czechia 41 1.2k 0.6× 1.5k 0.9× 1.6k 1.5× 898 1.3× 255 0.4× 159 5.2k

Countries citing papers authored by Jukka Hakkola

Since Specialization
Citations

This map shows the geographic impact of Jukka Hakkola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jukka Hakkola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jukka Hakkola more than expected).

Fields of papers citing papers by Jukka Hakkola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jukka Hakkola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jukka Hakkola. The network helps show where Jukka Hakkola may publish in the future.

Co-authorship network of co-authors of Jukka Hakkola

This figure shows the co-authorship network connecting the top 25 collaborators of Jukka Hakkola. A scholar is included among the top collaborators of Jukka Hakkola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jukka Hakkola. Jukka Hakkola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Szabó, Zoltán, J. Peters, Outi Kummu, et al.. (2024). Inhibition of activin receptor 2 signalling ameliorates metabolic dysfunction–associated steatotic liver disease in western diet/L-NAME induced cardiometabolic disease. Biomedicine & Pharmacotherapy. 175. 116683–116683. 2 indexed citations
2.
Kummu, Outi, et al.. (2024). The fungicide propiconazole induces hepatic steatosis and activates PXR in a mouse model of diet-induced obesity. Archives of Toxicology. 99(3). 1203–1221. 3 indexed citations
3.
Kummu, Outi, Vesa Koivukangas, Heidi Hautajärvi, et al.. (2022). Pregnane X receptor‒4β‐hydroxycholesterol axis in the regulation of overweight‐ and obesity‐induced hypertension. University of Oulu Repository (University of Oulu). 7 indexed citations
4.
Hukkanen, Janne, et al.. (2022). Nuclear Receptor PXR in Drug-Induced Hypercholesterolemia. Cells. 11(3). 313–313. 25 indexed citations
5.
Kummu, Outi, Terhi Piltonen, Laure Morin‐Papunen, et al.. (2020). Obesity Represses CYP2R1 , the Vitamin D 25‐Hydroxylase, in the Liver and Extrahepatic Tissues. JBMR Plus. 4(11). e10397–e10397. 51 indexed citations
6.
Salonurmi, Tuire, Justiina Ronkainen, Tuulia Hyötyläinen, et al.. (2020). 4β-Hydroxycholesterol Signals From the Liver to Regulate Peripheral Cholesterol Transporters. Frontiers in Pharmacology. 11. 361–361. 16 indexed citations
7.
Hakkola, Jukka, et al.. (2017). Extranuclear Sirtuins and Metabolic Stress. Antioxidants and Redox Signaling. 28(8). 662–676. 52 indexed citations
8.
Dimova, Elitsa Y., Sohvi Hörkkö, Helena Gylling, et al.. (2016). Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology. 36(4). 608–617. 75 indexed citations
9.
Hu, Hao, et al.. (2015). Tumour suppressor protein p53 regulates the stress activated bilirubin oxidase cytochrome P450 2A6. Toxicology and Applied Pharmacology. 289(1). 30–39. 8 indexed citations
10.
Hukkanen, Janne, Jukka Hakkola, & Jaana Rysä. (2013). Pregnane X receptor (PXR) – a contributor to the diabetes epidemic?. Drug metabolism and drug interactions. 29(1). 3–15. 37 indexed citations
11.
Anttila, Sisko, Hannu Raunio, & Jukka Hakkola. (2010). Cytochrome P450–Mediated Pulmonary Metabolism of Carcinogens. American Journal of Respiratory Cell and Molecular Biology. 44(5). 583–590. 62 indexed citations
12.
Korjamo, Timo, Ari Tolonen, Miia Turpeinen, et al.. (2009). Effects of Selective Serotonin Reuptake Inhibitors on Timolol Metabolism in Human Liver Microsomes and Cryo‐Preserved Hepatocytes. Basic & Clinical Pharmacology & Toxicology. 106(4). 302–309. 16 indexed citations
13.
Heikkinen, Terho, Jukka Hakkola, Kati Hakala, et al.. (2005). Functional role of P-glycoprotein in the human blood-placental barrier. Clinical Pharmacology & Therapeutics. 78(2). 123–131. 99 indexed citations
14.
Hukkanen, Janne, Olavi Pelkonen, Jukka Hakkola, & Hannu Raunio. (2002). Expression and Regulation of Xenobiotic-Metabolizing Cytochrome P450 (CYP) Enzymes in Human Lung. Critical Reviews in Toxicology. 32(5). 391–411. 245 indexed citations
15.
Pelkonen, Olavi, et al.. (2002). In Vitro Screening of Cytochrome P450 Induction Potential. PubMed. 105–137. 4 indexed citations
16.
Hakkola, Jukka, Hannu Raunio, Raija Purkunen, et al.. (2001). Cytochrome P450 3A Expression in the Human Fetal Liver: Evidence that CYP3A5 Is Expressed in Only a Limited Number of Fetal Livers. Neonatology. 80(3). 193–201. 56 indexed citations
17.
Hakkola, Jukka, Olavi Pelkonen, Markku Pasanen, & Hannu Raunio. (1998). Xenobiotic-Metabolizing Cytochrome P450 Enzymes in the Human Feto-Placental Unit: Role in Intrauterine Toxicity. Critical Reviews in Toxicology. 28(1). 35–72. 179 indexed citations
18.
Anttila, Sisko, Janne Hukkanen, Jukka Hakkola, et al.. (1997). Expression and Localization of CYP3A4 and CYP3A5 in Human Lung. American Journal of Respiratory Cell and Molecular Biology. 16(3). 242–249. 134 indexed citations
20.
Hakkola, Jukka, et al.. (1992). 7‐Alkoxyquinoline O‐dealkylation by microsomes from human liver and placenta.. British Journal of Clinical Pharmacology. 34(5). 415–420. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026